Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Tofts

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal studyG R Davies, A Hadjiprocopis, D R Altmann, et al.
Journal of Neurology|April 19, 2005
Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosisG R Davies, D R Altmann, A Hadjiprocopis, et al.
Neurology|February 1, 1990
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancementA G Kermode, P S Tofts, A J Thompson, et al.
Journal of Neurology|December 4, 2003
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cordJ P Mottershead, K Schmierer, M Clemence, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 1999
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbolsP S Tofts, G Brix, D L Buckley, et al.
AJNR. American Journal of Neuroradiology|May 15, 2007
Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurementsB H Ridha, M R Symms, D J Tozer, et al.
Annals of Neurology|April 18, 1998
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosisM Filippi, M A Horsfield, H J Adèr, et al.
Magma (New York, N.Y.)|September 8, 2006
Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differencesP S Tofts, S C A Steens, M Cercignani, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal studyG R Davies, A Hadjiprocopis, D R Altmann, et al.
Journal of Neurology|April 19, 2005
Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosisG R Davies, D R Altmann, A Hadjiprocopis, et al.
Neurology|February 1, 1990
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancementA G Kermode, P S Tofts, A J Thompson, et al.
Journal of Neurology|December 4, 2003
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cordJ P Mottershead, K Schmierer, M Clemence, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 1999
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbolsP S Tofts, G Brix, D L Buckley, et al.
AJNR. American Journal of Neuroradiology|May 15, 2007
Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurementsB H Ridha, M R Symms, D J Tozer, et al.
Annals of Neurology|April 18, 1998
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosisM Filippi, M A Horsfield, H J Adèr, et al.
Magma (New York, N.Y.)|September 8, 2006
Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differencesP S Tofts, S C A Steens, M Cercignani, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 15